Dr. Vedant Kabra PRINCIPAL DIRECTOR SURGICAL ONCOLOGY

About Dr. Vedant Kabra 

Dr. Vedant Kabra is a senior Oncologist at Fortis Memorial Research Institute, with deep expertise in the medical management of cancer across multiple tumour types. With over 15 years of oncology practice, Dr. Kabra is recognised for experience in chemotherapy, targeted therapy, immunotherapy protocols, and the management of treatment-related complications. Trained at India’s premier cancer institutions and with international exposure to evidence-based oncology practice, Dr. Kabra brings both technical skill and compassionate patient-centred care to complex oncology cases. A growing number of patients from Kazakhstan, Uzbekistan, and Russia seek cancer treatment at Fortis Memorial Research Institute, drawn by 5-year survival rates matching European centres, access to the same immunotherapy agents used globally, and costs 60–70% lower than in Germany or Turkey. MediKaya Healthcare coordinates all Russian-language consultation, visa support, and accommodation for CIS cancer patients.

Experience Overview

• Dr. Vedant Kabra brings over 25 years of experience in the field of Surgical Oncology.
• He has performed over 12,000 cancer surgeries, specializing in complex oncosurgical procedures, including Robotic Surgery for Cancer.
• Dr. Kabra is the Principal Director of Surgical Oncology at Fortis Memorial Research Institute, Gurugram, where he leads the oncology department.
• He has trained at prestigious institutions such as Tata Memorial Hospital, Mumbai, and the National Cancer Centre, Singapore, gaining advanced skills in cancer surgery.
• Dr. Kabra has also contributed significantly to academic advancements in surgical oncology, serving as faculty at various national and international conferences, and authoring numerous papers and book chapters.
• He is actively involved in cancer awareness initiatives, conducting health talks, self-examination camps, and awareness drives.
• As a leader in the fight against tobacco-related cancers, he spearheads the Voice of Tobacco Victims (VoTV) initiative in Gurugram and Haryana.

Conditions Treated

Dr. Vedant Kabra specialises in the diagnosis and management of:

• Breast Cancer Treatment
• Lung Cancer Management
• Colorectal & Gastrointestinal Cancer
• Head & Neck Cancer
• Haematological Cancers (Leukaemia, Lymphoma)
• Prostate Cancer
• Cervical & Gynaecological Cancer
• Thyroid Cancer
• Chemotherapy Administration & Management
• Immunotherapy & Targeted Therapy

Why CIS Patients Choose Dr. Vedant Kabra?

Patients from Kazakhstan, Uzbekistan, Russia and across the CIS region choose Dr. Vedant Kabra at Fortis Memorial Research Institute because:

India’s top cancer hospitals achieve 5-year survival rates of 80%+ for breast cancer — significantly above the 43% average in Russia and 60–65% in Kazakhstan. Patients access the same treatments available in Germany and the USA (proton therapy, immunotherapy, CAR-T cell therapy) at 60–70% lower cost. Waiting time for oncology consultation in India: 48–72 hours. In Kazakhstan: 3–6 months.

Through MediKaya Healthcare, all international patients from CIS countries receive dedicated Russian-speaking coordination from the moment of first inquiry through to post-treatment follow-up. Dr. Kabra’s team at Fortis Memorial Research Institute is experienced in treating international patients and ensures all communication, medical reports, and treatment plans are clearly explained in Russian.

Professional Memberships

• Member of the Association of Surgeons of India (ASI)
• Member of the Indian Association of Surgical Oncology (IASO)
• Member of the Royal College of Surgeons of Edinburgh (MRCS)
• Member of the National Academy of Medical Sciences (MNAMS)
• Member of the Indian Association of Gastrointestinal Endo-Surgeons (IAGES)

Awards:

• University Gold Medal (BHU) for standing first in the Final MBBS Examination
• Best Undergraduate Student of Surgery in Uttar Pradesh (1995-96)
• Best Resident at the Institute of Medical Sciences, Banaras Hindu University (1997-98)
• Best Research Paper Award at the Annual Conference of the Association of Surgeons of India (Ahmedabad, 1998)
• Second Best Poster Award at the Annual Conference of the Indian Association of Surgical Oncology (Lucknow, 2003)
• Recognized for outstanding academic contributions in Surgical Oncology and Robotic Surgery.

Specialty Interests:

• Surgical Oncology, specializing in complex cancer surgeries
• Robotic Surgery for cancer treatment
• Minimally invasive surgery techniques in oncological care
• Cancer awareness and prevention
• Tobacco cessation, leading the Voice of Tobacco Victims (VoTV) initiative

Languages Spoken

• English
• Hindi
• Punjabi

Frequently Asked Questions

Q: Is cancer treatment in India safe for international patients?

A: Yes. JCI-accredited hospitals with dedicated international oncology teams, Russian-speaking coordinators, and 24-hour patient support. Hospitals like BLK-Max, Medanta, and Max have treated thousands of CIS cancer patients with documented outcomes.

Q: How does chemotherapy cost in India compare to Kazakhstan?

A: Chemotherapy in India costs 50–70% less than in Kazakhstan’s private hospitals. A full course of carboplatin-paclitaxel chemotherapy in India is approximately $800–$1,500 per cycle vs $2,500–$4,000 per cycle privately in Kazakhstan.

Q: Can I get immunotherapy in India? Is it available?

A: Yes. Immunotherapy drugs including pembrolizumab (Keytruda), nivolumab (Opdivo), and others are available at major Indian hospitals. Generic versions approved by Indian regulators cost 80% less than branded versions in CIS countries.

Q: How do I get a second opinion from an Indian oncologist before travelling?

A: Send your biopsy reports, PET-CT or CT scans, histopathology reports, and current treatment plan to MediKaya Healthcare via WhatsApp or email. An Indian oncologist will review and provide a second opinion report within 48 hours — free of charge.

Q: Can a patient continue chemotherapy started in Kazakhstan in India?

A: Yes, in most cases. Indian oncologists review the existing protocol and either continue it or recommend modifications. All communication with your Kazakhstan oncologist can be coordinated by MediKaya Healthcare.